The following Pre-Congress Course is supported by Eli Lilly and Company

OBESITY MANAGEMENT MEDICATIONS FOR SURGEONS 
Date: Tuesday, 9 September 
Time: 09:30 – 17:00
Location: Metropolitan Santiago, Hall F 
Pre-registration is required

This course will be interactive to allow as much exchange between the experts on the podium and in the audience to understand how obesity medications can be optimised before and after metabolic and bariatric surgery. The objectives are to increase the use of obesity medications before and after metabolic and bariatric surgery by reducing side effects and by increasing long term benefit. The course will explore ways how obesity medications can result in an increased number of metabolic and bariatric surgery operations to allow better care for more people with the disease of obesity. The top international thought leaders will explain heir interpretation of the data but also share their opinions on what the future may hold.

Learning Objectives

By the end of this course, participants will be able to:

– Understand the potential of using obesity medications before and after metabolic and bariatric surgery

– Understand the reasons why the numbers of metabolic and bariatric surgery operations have declined internationally and how the use of obesity medications can increase the numbers of metabolic and bariatric surgery operations

– Understand how the side effects of obesity medications can be reduced and how the long term benefits of obesity medications can be enhanced before and after metabolic and bariatric surgery

Click here to see the course agenda details.